Section Arrow
Quote
WHWK.NASDAQ
- Whitehawk Therapeutics Inc
Quotes are at least 15-min delayed:2025/06/20 07:44 EDT
Last
 2.05
+0.04 (+1.99%)
Day High 
2.115 
Prev. Close
2.01 
1-M High
2.2 
Volume 
110.37K 
Bid
1.96
Ask
2.09
Day Low
1.92 
Open
2 
1-M Low
1.64 
Market Cap 
94.69M 
Currency USD 
P/E 13.4 
%Yield -- 
10-SMA 1.92 
20-SMA 1.86 
50-SMA 1.71 
52-W High 3.812 
52-W Low 1.21 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.15/-0.74
Enterprise Value
95.25M
Balance Sheet
Book Value Per Share
4.71
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
25.98M
Operating Revenue Per Share
0.47
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
APVOAptevo Therapeutics Inc5.13+2.31+81.91%0PE
NCNANuCana plc0.1222-0.0014-1.13%-- 
BDRXBiodexa Pharmaceuticals plc1.03+0.2337+29.35%-- 
RXRXRecursion Pharmaceuticals5.11+0.27+5.58%-- 
PCSAProcessa Pharmaceuticals0.242-0.018-6.92%-- 
Quotes are at least 15-min delayed：2025/06/20 07:44 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.